ZA200704972B - Processes for producing 4-aminoquinazolines - Google Patents

Processes for producing 4-aminoquinazolines

Info

Publication number
ZA200704972B
ZA200704972B ZA200704972A ZA200704972A ZA200704972B ZA 200704972 B ZA200704972 B ZA 200704972B ZA 200704972 A ZA200704972 A ZA 200704972A ZA 200704972 A ZA200704972 A ZA 200704972A ZA 200704972 B ZA200704972 B ZA 200704972B
Authority
ZA
South Africa
Prior art keywords
aminoquinazolines
processes
producing
Prior art date
Application number
ZA200704972A
Other languages
English (en)
Inventor
Richard A Silva
Jones Andrew
Todd A Blythe
Original Assignee
Vertex Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharma filed Critical Vertex Pharma
Publication of ZA200704972B publication Critical patent/ZA200704972B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/241,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/40Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/58Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200704972A 2004-12-17 2005-12-15 Processes for producing 4-aminoquinazolines ZA200704972B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63727804P 2004-12-17 2004-12-17

Publications (1)

Publication Number Publication Date
ZA200704972B true ZA200704972B (en) 2008-09-25

Family

ID=36588571

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200704972A ZA200704972B (en) 2004-12-17 2005-12-15 Processes for producing 4-aminoquinazolines

Country Status (18)

Country Link
US (1) US20060166963A1 (pl)
EP (2) EP2366696A1 (pl)
JP (2) JP5030787B2 (pl)
KR (1) KR20070091660A (pl)
CN (1) CN101111487A (pl)
AR (1) AR053317A1 (pl)
AT (1) ATE549314T1 (pl)
AU (1) AU2005316454B2 (pl)
BR (1) BRPI0519600A2 (pl)
CA (1) CA2591588A1 (pl)
ES (1) ES2382200T3 (pl)
IL (1) IL183983A (pl)
MX (1) MX2007007446A (pl)
PL (1) PL382927A1 (pl)
RU (1) RU2007127315A (pl)
TW (1) TW200635905A (pl)
WO (1) WO2006066044A2 (pl)
ZA (1) ZA200704972B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2004000409A1 (es) * 2003-03-03 2005-01-07 Vertex Pharma Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
US7713983B2 (en) * 2003-03-03 2010-05-11 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US7928107B2 (en) * 2004-09-02 2011-04-19 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US7718658B2 (en) * 2004-09-02 2010-05-18 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US8283354B2 (en) * 2004-09-02 2012-10-09 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
RU2008123811A (ru) * 2005-11-14 2009-12-27 Вертекс Фармасьютикалз Инкорпорейтед (Us) Хиназолины, используемые в качестве модуляторов потенциалзависимых ионных каналов
CA2634491A1 (en) * 2005-12-21 2007-06-28 Painceptor Pharma Corporation Compositions and methods for modulating gated ion channels
WO2008069976A2 (en) 2006-12-01 2008-06-12 President And Fellows Of Harvard College Compounds and methods for enzyme-mediated tumor imaging and therapy
US8786436B2 (en) * 2009-08-31 2014-07-22 Omron Corporation Multiple optical axis photoelectric sensor
CN106632088B (zh) * 2015-10-30 2019-04-19 华南理工大学 一种基于喹唑啉酮类化合物的聚集诱导发光探针及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637693A (en) * 1968-07-12 1972-01-25 Du Pont Hydroxyarylquinazolines and their use as uv-absorbers
US3819628A (en) * 1972-07-31 1974-06-25 Sandoz Ag 2-phenyl-4-substituted amino-quinazolines and nitrates thereof
DE19756388A1 (de) * 1997-12-18 1999-06-24 Hoechst Marion Roussel De Gmbh Substituierte 2-Aryl-4-amino-chinazoline
US6184226B1 (en) * 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
US6608053B2 (en) * 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
CN1466754A (zh) * 2000-09-29 2004-01-07 ���µ�����ҵ��ʽ���� 光盘装置
CL2004000409A1 (es) * 2003-03-03 2005-01-07 Vertex Pharma Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu
US7713983B2 (en) * 2003-03-03 2010-05-11 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US7189733B2 (en) * 2003-03-12 2007-03-13 Millennium Pharmaceuticals, Inc. Compositions and methods for inhibiting TGF-β
US7718658B2 (en) * 2004-09-02 2010-05-18 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
US8283354B2 (en) * 2004-09-02 2012-10-09 Vertex Pharmaceuticals Incorporated Quinazolines useful as modulators of ion channels
RU2008123811A (ru) * 2005-11-14 2009-12-27 Вертекс Фармасьютикалз Инкорпорейтед (Us) Хиназолины, используемые в качестве модуляторов потенциалзависимых ионных каналов

Also Published As

Publication number Publication date
RU2007127315A (ru) 2009-01-27
US20060166963A1 (en) 2006-07-27
CN101111487A (zh) 2008-01-23
BRPI0519600A2 (pt) 2009-02-25
ES2382200T3 (es) 2012-06-06
MX2007007446A (es) 2008-01-14
WO2006066044A3 (en) 2007-05-10
EP2366696A1 (en) 2011-09-21
IL183983A0 (en) 2007-10-31
PL382927A1 (pl) 2008-02-04
JP5030787B2 (ja) 2012-09-19
CA2591588A1 (en) 2006-06-22
KR20070091660A (ko) 2007-09-11
IL183983A (en) 2012-04-30
AR053317A1 (es) 2007-05-02
JP2008524238A (ja) 2008-07-10
TW200635905A (en) 2006-10-16
JP2012056968A (ja) 2012-03-22
AU2005316454B2 (en) 2012-09-06
EP1828150B1 (en) 2012-03-14
ATE549314T1 (de) 2012-03-15
WO2006066044A2 (en) 2006-06-22
EP1828150A2 (en) 2007-09-05
AU2005316454A1 (en) 2006-06-22

Similar Documents

Publication Publication Date Title
IL180247A0 (en) Method for producing 4-
GB0416001D0 (en) Process
GB0407329D0 (en) Process
GB0418654D0 (en) Process
GB0418046D0 (en) Eantioselective process
IL177233A0 (en) Method for producing polyisobutenylphenols
GB0404793D0 (en) Process
ZA200704972B (en) Processes for producing 4-aminoquinazolines
PL1831223T3 (pl) Sposób wytwarzania L-biopteryny
GB0421928D0 (en) Process
GB0414847D0 (en) Process
GB0413053D0 (en) Process
GB0419075D0 (en) Process
GB0420563D0 (en) Process
GB0410289D0 (en) Process
GB0406894D0 (en) Process
EP1754738A4 (en) PROCESS FOR PREPARING POLYPYRIDINIUM
GB0412875D0 (en) Process
GB0414335D0 (en) Process
GB0411583D0 (en) Process
GB0411185D0 (en) Process
GB0420561D0 (en) Process
GB0420564D0 (en) Process
GB0401540D0 (en) Process
GB0410276D0 (en) Process